Synthesis of the human aldose reductase inhibitor rubrolide L

The first synthesis of rubrolide L, a marine ascidian butenolide and a potent inhibitor of human aldose reductase, has been achieved by two tactically distinct pathways in 4–5 steps and 37–42% overall yield from commercially available 3-chlorotetronic acid.